Android app Apple app link

TELO Rises on Promising Telomir-1 Preclinical Results

By Yahoo! Finance   |   1 week ago
TELO Rises on Promising Telomir-1 Preclinical Results

Telomir Pharmaceuticals, Inc. (NASDAQ: TELO) showcases promising results for its drug Telomir-1 in a preclinical model of Wilson's disease, with plans for IND submission and human trials. Analysts predict a 688% upside with a target price of $15.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.